Brind.

Huntsman is appointed CEO of Vivos Therapeutics, and a UC Irvine study informs the company's focus.

3 reports, 1 independent Updated Jul 22
Gone quiet
Reports
3
Developments
2
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Huntsman is appointed CEO of Vivos Therapeutics, and a UC Irvine study informs the company's focus.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Huntsman takes the CEO role at Vivos Therapeutics, informed by UC Irvine research.1 source
  2. Vivos products gain FDA clearance and CMS approval for Medicare access.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • PR NewswireIgnored and Undiagnosed: Sleep Apnea Threatens Women's Cognitive Health Alzheimer's disease affects more than 6 million Americans, and emerging research identifies Obstructive Sleep Apnea (OSA) as a
  • PR NewswireCPAP Is Failing Patients With OCD--Vivos Exposes the Hidden Mental Health Risk Vivos Therapeutics highlights the overlooked link between Obstructive Sleep Apnea (OSA) and mental health disorders like
  • Unknown outlet